News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
92,869 Results
Type
Article (6738)
Company Profile (39)
Press Release (86092)
Section
Business (27877)
Career Advice (130)
Deals (4010)
Drug Delivery (31)
Drug Development (14152)
Employer Resources (12)
FDA (2873)
Job Trends (2139)
News (49457)
Policy (6013)
Tag
Academia (427)
Allergies (27)
Alliances (9032)
Alzheimer's disease (254)
Antibody-drug conjugate (ADC) (36)
Approvals (2875)
Artificial intelligence (36)
Best Places to Work (1823)
Biosimilars (62)
Biotechnology (26)
Breast cancer (50)
Cancer (392)
Career advice (112)
Cell therapy (79)
Clinical research (11452)
Collaboration (162)
Compensation (35)
COVID-19 (541)
C-suite (38)
Data (346)
Diabetes (32)
Diagnostics (563)
Earnings (9438)
Events (11766)
Executive appointments (101)
FDA (3150)
Funding (120)
Gene therapy (75)
GLP-1 (105)
Government (1298)
Healthcare (1956)
Immunology and inflammation (27)
Infectious disease (570)
Inflammatory bowel disease (45)
IPO (1836)
Job creations (387)
Job search strategy (108)
Layoffs (53)
Legal (558)
Lung cancer (68)
Lymphoma (24)
Manufacturing (95)
Medical device (1194)
Medtech (1195)
Mergers & acquisitions (2255)
Metabolic disorders (72)
Neuroscience (318)
NextGen: Class of 2025 (702)
Non-profit (349)
Northern California (417)
Obesity (24)
Opinion (44)
Patents (23)
People (7956)
Phase I (3760)
Phase II (4772)
Phase III (4191)
Pipeline (210)
Policy (33)
Postmarket research (297)
Preclinical (1462)
Press Release (66)
Radiopharmaceuticals (35)
Rare diseases (63)
Real estate (921)
Regulatory (4717)
Research institute (388)
Series A (29)
Southern California (418)
Startups (573)
United States (3589)
Vaccines (167)
Date
Today (25)
Last 7 days (175)
Last 30 days (539)
Last 365 days (6504)
2025 (1074)
2024 (6548)
2023 (7005)
2022 (9135)
2021 (9522)
2020 (8199)
2019 (5879)
2018 (4538)
2017 (5093)
2016 (4649)
2015 (5315)
2014 (3766)
2013 (2930)
2012 (3020)
2011 (3172)
2010 (2597)
Location
Africa (92)
Asia (7504)
Australia (880)
California (990)
Canada (213)
China (146)
Colorado (31)
Connecticut (23)
Delaware (32)
Europe (13832)
Florida (110)
Illinois (40)
Indiana (37)
Japan (24)
Maryland (290)
Massachusetts (671)
Michigan (23)
Minnesota (42)
New Jersey (387)
New York (275)
North Carolina (181)
Northern California (417)
Ohio (37)
Pennsylvania (162)
South America (135)
Southern California (418)
Texas (117)
Washington State (79)
92,869 Results for "insitu biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
AbbVie and Umoja Biopharma Announce Strategic Collaboration to Develop Novel In-Situ CAR-T Cell Therapies
AbbVie (NYSE: ABBV), and Umoja Biopharma (Umoja), an early clinical-stage biotechnology company, today announced two exclusive option and license agreements to develop multiple in-situ generated CAR-T cell therapy candidates in oncology using Umoja’s proprietary VivoVecTM platform.
January 4, 2024
·
5 min read
Business
InSitu Biologics Announces License Agreement With Mayo Clinic For Co-Development of Anti-Cancer Therapeutics
InSitu Biologics, Inc. is pleased to announce that it has entered into an agreement with the Mayo Foundation for Medical Education and Research to further develop its prolonged-release drug delivery technology for anti-cancer therapeutics.
December 22, 2022
·
2 min read
BioMidwest
InSitu Biologics Shares Latest Investigational Work at ASRA Meeting - November 18, 2022
InSitu Biologics, Inc. will share the latest investigational work on its multi-phase drug delivery matrix at the upcoming 21st Annual Pain Medicine Meeting of the American Society of Regional Anesthesia on November 18th , 2022.
November 17, 2022
·
1 min read
Manufacturing
Merck Snaps Up WuXi Biologics Facility in Ireland for $500M
The acquisition from Wuxi Biologics, the embattled CDMO named in the BIOSECURE Act, marks another expansion of Merck’s manufacturing operations in Ireland.
January 6, 2025
·
1 min read
·
Annalee Armstrong
Business
Dr. M. Yaman Joins InSitu Biologics Medical Advisory Board
InSitu Biologics is very pleased to announce the appointment of Dr. M. Yaman, FRCS, FACS, to its Medical Advisory Board.
April 22, 2022
·
2 min read
BioMidwest
InSitu Biologics Shares Latest Investigational Work at ASRA Meeting
InSitu Biologics, Inc. will share the latest investigational work on its hydrogel-lipid-microparticle matrix at the upcoming 47th Annual Regional and Acute Pain Medicine Meeting of the American Society of Regional Anesthesia in April 2022.
March 31, 2022
·
1 min read
Press Releases
Qu Biologics’ Immunomodulator Clears Senescence
February 11, 2025
·
5 min read
Press Releases
Tanvex BioPharma Completes Acquisition of Bora Biologics, Launching New Era in Biologics Development
January 19, 2025
·
4 min read
Press Releases
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
March 3, 2025
·
2 min read
Press Releases
Biocon Biologics Launches Yesintek™ (ustekinumab-kfce) Biosimilar to Stelara® in the United States
February 24, 2025
·
8 min read
1 of 9,287
Next
